⌘K
Loading ticker…
As of 2026-08-24, Clover Health Investments, Corp (CLOV) has a 3-month relative strength percentile of 76 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 67. The current market Stance is 47.8 (Neutral). Sector: Financials, ranked 4 of 11. Average daily range 5.3%, relative volume 0.62×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
CLOV is held by 20 ETFs as of May 2026. Top owner: VTWO at 0.05% weight, $8M notional. Top 3 carry $22M.
Held by 42 ETFs · $93M across latest filings · largest weight 1.60% (XHS).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.05% | $8M | +0.02 pp |
| SCHASchwab U.S. Small-Cap ETF | 0.03% | $8M | +0.01 pp |
| FNDA | 0.06% | $6M | +0.04 pp |
| VHTVanguard Health Care ETF | 0.03% | $5M | +0.01 pp |
| VTWG | 0.09% | $2M | +0.04 pp |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.00% |
| $960K |
| — |
| ONEQ | 0.01% | $699K | — |
| HEAL | 1.39% | $348K | +0.26 pp |
| AVSC | 0.01% | $293K | new |
| VTHRVanguard Russell 3000 ETF | 0.00% | $126K | — |
Showing 10 of 20 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CLOV Jan avg: 19.60% median: 20.00% win: 75% σ: 25.11% n: 4 2022-04-12 → 2026-07-31 | CLOV Feb avg: -6.71% median: -8.13% win: 0% σ: 4.22% n: 4 2022-04-12 → 2026-07-31 | CLOV Mar avg: -17.36% median: -12.68% win: 0% σ: 12.85% n: 4 2022-04-12 → 2026-07-31 | CLOV Apr avg: 0.95% median: -12.60% win: 20% σ: 31.39% n: 5 2022-04-12 → 2026-07-31 | CLOV May avg: 25.12% median: 14.66% win: 60% σ: 34.22% n: 5 2022-04-12 → 2026-07-31 | CLOV Jun avg: 3.68% median: 5.93% win: 60% σ: 20.17% n: 5 2022-04-12 → 2026-07-31 | CLOV Jul avg: 21.73% median: 30.84% win: 80% σ: 30.10% n: 5 2022-04-12 → 2026-07-31 | CLOV Aug avg: 6.59% median: -0.99% win: 50% σ: 21.63% n: 4 2022-04-12 → 2026-07-31 (current) | CLOV Sep avg: -7.10% median: -5.17% win: 50% σ: 23.50% n: 4 2022-04-12 → 2026-07-31 | CLOV Oct avg: 10.67% median: 4.15% win: 50% σ: 26.42% n: 4 2022-04-12 → 2026-07-31 | CLOV Nov avg: -16.37% median: -16.31% win: 0% σ: 10.66% n: 4 2022-04-12 → 2026-07-31 | CLOV Dec avg: -10.19% median: -7.55% win: 25% σ: 13.67% n: 4 2022-04-12 → 2026-07-31 |